Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Pathologic grading of malignant pleural mesothelioma : an evidence-based proposal
Authors:ID Pelosi, Giuseppe (Author)
ID Papotti, Mauro (Author)
ID Righi, Luisella (Author)
ID Rossi, Giulio (Author)
ID Ferrero, Stefano (Author)
ID Bosari, Silvano (Author)
ID Kern, Izidor, Klinika Golnik (Author)
Files:URL URL - Source URL, visit https://www.jto.org/article/S1556-0864(18)30773-1/pdf
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo UKPBAG - University Clinic of Respiratory and Allergic Diseases Golnik
Abstract:Introduction: A pathologic grading system (PGS) for malignant pleural mesothelioma (MPM) is warranted to better identify different risk categories of patients, plan therapeutic options, and activate clinical trials. Methods: A series of 940 patients with MPM (328 in a training set and 612 in a validation set) that was diagnosed between October 1980 and June 2015 at the participant institutions was retrospectively assembled. A PGS was constructed by attributing to each histologic parameter, independent at multivariate analysis with excellent reproducibility (κ > 0.75), different scores based on the increase in corresponding hazard ratios. The relevant PGS score thus ranged from 0 to 8 points for individual patients with MPM. Conclusions: The PGS was constructed by taking into consideration the histological subtyping of MPM (epithelioid/biphasic = 0 points; sarcomatoid = 2 points), necrosis (absent = 0 points versus present = 1 point), mitotic count per 1 mm2 (cutoffs as follows: 1-2 = 0 points, 3-5 = 1 point, 6-9 = 2 points, or ≥10 = 4 points), and Ki-67 labeling index based on 2000 cells (<30% = 0 points versus ≥30 = 1 point), all of which are independent factors in both patient sets after adjustment for stage and age at diagnosis. No heterogeneity was seen across the validation centers (p = 0.19). Epithelioid/biphasic MPM patterning and biopsy versus resection did not affect survival, whereas the PGS outperformed mitotic count and Ki-67 LI in both the training (area under the curve receiver operating characteristic = 0.76) and validation sets (area under the curve receiver operating characteristic = 0.73) (p < 0.01). Patient survival progressively deteriorated from a score of 0 (median times of 26.3 and 26.9 months) to a score 1 to 3 (median times of 12.8 and 14.4 months) and a score of 4 to 8 (median times of 3.7 and 7.7 months) in both sets of patients, with the hazard ratio for a 1-point increase in score being 1.46 (95% confidence interval: 1.36-1.56) in the training set and 1.28 (95% confidence interval: 1.22-1.34) in the validation set (after adjustment for age and [when available] tumor stage). The PGS was effective even in subgroup analysis (epithelioid, biphasic, and sarcomatoid tumors). Discussion: A simple and reproducible multiparametric PGS effectively predicted survival in patients with MPM.
Keywords:carcinoma, mesothehttp://dirros.openscience.si/admin/GradivoDatoteke.php?id=12688lioma, pleura, survival, grading
Publication status:Published
Publication version:Version of Record
Place of publishing:ZDA
Publisher:Elsevier
Year of publishing:2018
Number of pages:str. 1750-1761
Numbering:Vol. 13, no. 11
PID:20.500.12556/DiRROS-12688 New window
UDC:616.2
ISSN on article:1556-1380
DOI:10.1016/j.jtho.2018.07.002 New window
COBISS.SI-ID:2048400497 New window
Copyright: © 2018 International Association for the Study of Lung Cancer
Note:Soavtorji: Mauro Papotti, Luisella Righi, Giulio Rossi, Stefano Ferrero, Silvano Bosari, Fiorella Calabrese, Izidor Kern, Patrick Maisonneuve, Angelica Sonzogni, Adriana Albini, Sergio Harari, Fausto Barbieri, Enrica Capelletto, Anna Maria Catino, Domenica Cavone, Angela De Palma, Nicola Fusco, Francesca Lunardi, Eugenio Maiorano, Andrea Marzullo, Silvia Novello, Nikolaos Papanikolaou, Giulia Pasello, Antonio Pennella, Federica Pezzuto, Alessandra Punzi, Elena Prisciandaro, Federico Rea, Lorenzo Rosso, Anna Scattone, Gabriella Serio; Nasl. z nasl. zaslona; Opis vira z dne 29. 10. 2018;
Publication date in DiRROS:20.11.2020
Views:1404
Downloads:534
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Journal of thoracic oncology
Shortened title:J. thorac. oncol.
Publisher:Lippincott
ISSN:1556-1380
COBISS.SI-ID:3745812 New window

Licences

License:Other
Description:Elsevier user licence
Licensing start date:06.06.2018

Secondary language

Language:Undetermined
Keywords:karcinom, mezoteliom, plevra, preživetje, ocenjevanje


Back